Marker Therapeutics MRKR
NASDAQ MRKR
$1.05 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Non Operating Investment Income (2013 - 2014)

Updated

Marker Therapeutics (MRKR) recorded Non Operating Investment Income of -$94,640 in Q3 2014, compared with -$168,392 a year earlier.

Analysis

Marker Therapeutics (MRKR) Non Operating Investment Income (2013 - 2014) Analysis & Trends

On a TTM basis, Marker Therapeutics' Non Operating Investment Income came in at -$263,032 as of Sep 30, 2014.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Marker Therapeutics 17.53 Mn -42.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 -94,640.00
Sep 30, 2013 -168,392.00
API Access

Marker Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=MRKR&period=max&api_key=YOUR_API_KEY